Wall Street Zen Upgrades Structure Therapeutics to Hold Rating
Structure Therapeutics (NASDAQ:GPCR) received a significant shift in its stock rating from Wall Street Zen, which upgraded the company from a “sell” to a “hold” rating in a report released…